Abstract :

: Hypoglycaemia is an important complication in the treatment of type 2 diabetes mellitus, because it   causes   recurrent   physical   and   psycho-social morbidity, and is sometimes fatal. The main objective of the study is to clinically audit the hypoglycaemic symptoms in type 2 diabetic patients in Jinnah Hospital, Lahore. This cross sectional clinical audit was done in Jinnah Hospital, Lahore during May 2020. The data was collected with the permission of ethical committee of hospital. The data was collected from type 2 diabetic patients who were enrolled during last 6 months in the hospital. We critically analyse the hypoglycemic symptoms of type 2 diabetic patients. The data was collected from 150 patients of Nishtar hospital, Multan for audit analysis. There were 70 males and 80 females. The age range was 40 to 70 years and the mean age was 58.95±5.67 for hypoglycaemic symptoms patients and 55.15±10.67 for without symptoms patients. It is concluded that hypoglycaemic symptoms are a common complication   of   diabetic   treatment,   and   efforts should be focused especially on insulin-treated patients    to    prevent    hypoglycaemia,    including education    on    hypoglycaemia    awareness,    self-monitoring of blood glucose and dietary advice.

---

Keywords :

DM, Hypoglycemia, Outcomes, Patients

---

References :

1. Maran A, Lomas J, Macdonald IA, Amiel SA. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively treated insulin dependent diabetes mellitus. Diabetologia. 1995;38:1412–1418.
2. Fanelli CG, Paramore DS, Hershey T, Terkamp C, Ovalle F, Craft S, et al. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes. 1998;47:1920–1927.
3. Cranston IA, Lomas J, Maran A, Macdonald IA, Amiel SA. Restoration of hypoglycaemia awareness in patients with long duration insulin dependent diabetes. Lancet. 1994;344:283–287.
4. Banarer S, Cryer PE. Hypoglycemia in type 2 diabetes. Med Clin North Am. 2004;88:1107–1116.
5. Segal SA, Paramore DS, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes. 2002;51:724–733.
6. Peacey SR, Rostami-Hodjegan A, George E, Tucker GT, Heller SR. The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humans. J Clin Endocrinol Metab. 1997;82:1458–1461.
7. Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med. 2001;161:1653–1659.
8. Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med. 1999;159:281–284.
9. Nattrass M, Lauritzen T. Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycemia in the treatment of type 2 diabetes? Int J Obesity. 2000;24(Suppl. 3):S21–S31.
10. Sotiropoulos A, Skliros EA, Tountas C, Apostolou U, Peppas TA, Pappas SI. Risk factors for severe hypoglycemia in type 2 diabetic patients admitted to hospital in Piraeus, Greece. East Mediterr Health J. 2005;11:485–489.
11. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med. 1997;157:1681–1686.